Results 141 to 150 of about 29,732,513 (224)

HTLV-1 HBZ inhibits DHX9 to reprogram circRNA biogenesis in ATLL. [PDF]

Tumour Virus Res
Ladet J, Bazire M, Fontrodona N, Van den Broeke A, Marçais A, Shallak M, Forlani G, Accolla RS, Bourgeois CF, Mortreux F.   +9 more
europepmc   +1 more source

Rewiring of the Apoptotic Rheostat in HTLV-1 Infection and Adult T-Cell Leukemia/Lymphoma. [PDF]

Cancers (Basel)
Darbandi A, Raimondi V, Ciccarese F, D'Agostino DM, Ciminale V.   +4 more
europepmc   +1 more source

CRISPR-mediated excision of HTLV-1 reduces proviral loads in PBMCs from HAM/TSP patients. [PDF]

J Neurovirol
Brancazio S, Khalili K, Jacobson S, Kaminski R.   +3 more
europepmc   +1 more source

Prevalence of HTLV-1 and HTLV-2 infection among transgender women in Brazil: A multicenter study. [PDF]

PLoS Negl Trop Dis
Amianti C, Bandeira LM, Moreira RC, Leal AF, Knauth DR, Magno L, Dourado I, de Queiroz RSB, Bassichetto KC, Saggese GSR, Veras MASM, Motta-Castro ARC.   +11 more
europepmc   +1 more source

Molecular and Phylogenetic Characterization of HTLV-1 Infection in Patients With Hematological Malignancies in the State of Pará, Northern Brazil. [PDF]

J Med Virol
Neto GDSP, Alves AV, Botelho BJS, Silva ASD, Carneiro DM, Burbano RMR, Ishak R, Vallinoto ACR, Vallinoto IMVC.   +8 more
europepmc   +1 more source

HTLV-1-Specific CTL Accumulation in CSF Contributes to Neuroinflammation in HTLV-1-Associated Myelopathy. [PDF]

Neurol Neuroimmunol Neuroinflamm
Nozuma S, Dozono M, Tanaka M, Kodama D, Yoshida T, Higuchi Y, Sakiyama Y, Matsuura E, Matsuzaki T, Takashima H, Kubota R.   +10 more
europepmc   +1 more source

Vitamins as modulators of Deltaretrovirus infection: implications for HTLV-1 and bovine leukemia virus-associated diseases. [PDF]

Arch Microbiol
Akbarin MM, Farjami Z, Álvarez HR.
europepmc   +1 more source

The HTLV-1 HBZ Oncoprotein and Its Role in Adult T-Cell Leukemia/Lymphoma. [PDF]

Cancers (Basel)
Accolla RS, Shallak M, Forlani G.
europepmc   +1 more source

Spontaneous lymphoproliferation differentiates two groups of HTLV-1 asymptomatic carriers: with and without high cell proliferation and death. [PDF]

Immunol Res
de Souza Porto M, Mitiko T, Folgosi V, Vasconcelos D, Domingues M, Haziot M, Smid J, Marcusso R, Nukui Y, Oliveira ACP, Assone T, Casseb J, Benard G.   +12 more
europepmc   +1 more source

[Prevalence of HTLV-1 infection in family members of index cases in PeruPrevalência familiar da infecção pelo HTLV-1 a partir de um caso índice no Peru]. [PDF]

Rev Panam Salud Publica
Bobadilla-Chuquiure MP, Quiliche-Arévalo L, Mejía F, Garrido-Pinzás G, Guardia D, Gonzales-Lagos E, Gotuzzo E.   +6 more
europepmc   +1 more source